Navigation Links
Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
Date:4/6/2009

LELYSTAD, The Netherlands, April 6 /PRNewswire/ -- Today, Pepscan reports that it has achieved a major scientific breakthrough through the use of its CLIPS-based synthetic peptide immunogen technology. By constructing synthetic 3D mimics of the ligand binding-site on CXCR7 it has induced functional antibodies against the formerly intractable GPCR target CXCR7. CXCR7 is novel therapeutic target thought to be involved in tumor angiogenesis.

"We are proud and confident with achieving this major breakthrough!" says Professor Rob H. Meloen, Pepscan's founder and Chief Scientific officer. "Since a number of years we have been working on developing our CLIPS technology through which we can synthesize 3D conformational mimics of protein active sites , allowing us to do site-specific immunization to come up with functional antibodies against very difficult targets such as G-protein coupled receptors, as we have now proven with CXCR7." Meloen states that the CLIPS-technology is not limited to application in the GPCR field but also offers possibilities with other therapeutically interesting target such as for instance ion-channels.

Pepscan's Chief Commercial Officer Dr. Peter van Dijken thinks that this technology might unlock a whole new area of interesting therapeutic targets that could so far not be addressed: "One-third of the interesting GPCR targets have proven to be "undrugable" until now. Our CLIPS technology provides a systematic and efficient way to unlock these targets and make them available to antibody therapy, that is a multi-billion dollar playing field to which Pepscan now holds the unique technological key!"

Pepscan indicated today that over the coming period, it will continue to technically and commercially develop its clips-based technology for additional targets and indications.

Therapeutic antibody therapy is well established. Monoclonal antibodies are produced outsid
'/>"/>

SOURCE Pepscan Therapeutics B.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pepscan Achieves First Milestone in Research Collaboration With Genmab
2. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
3. VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit
4. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
5. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
6. Level 3 Inspection Achieves 100% Compliance in ISO 9001 & AS 9100 Certification
7. Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate
8. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
9. SleepQuest Achieves Coveted Accreditation
10. Bioenergy D-Ribose Achieves Highest Safety Standard
11. Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014  3D Communications, a leading provider of strategic communications services to ... events in the United States and ... Cox , JD, is returning to the firm,s Washington, ... 3D after more than two years of service as Associate Commissioner ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. 14, ... with two institutes from the National Institutes of Health ... bringing safer, more effective treatments to patients on a ... for Advancing Translational Sciences (NCATS) and the National Eye ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
(Date:1/14/2014)... 2014 During the 1600’s through the 1800’s ... Doctor’s Plague.” In this time period, doctors did not know ... times, to the death of vulnerable patients. In the same ... they may be unwittingly transmitting herpes viruses to their patients. ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... Keck Graduate Institute,(KGI) today announced a partnership with ... forum to help women managers advance in the,life ... forum from Jan. 13-18, 2008. Attendees will,have the ... executives from,pharmaceutical, medical device and biotechnology companies along ...
... 21 Nile Therapeutics Inc., (OTC,Bulletin Board: SPDU) ... disease, is pleased to announce the,appointments of Daron ... as the Vice President of Development. Mr. ... Chief Operating Officer,and was appointed Chief Financial Officer ...
... of Physics Dr. Satyendra Kumar recently was honored ... Directors Award for Excellence for recognition of exceptional ... matter physics proposals. In all, seven program directors ... Arlington, Va. , The NSF Directors Award ...
Cached Biology Technology:KGI and Smith College Establish Leadership Forum for Women in Bioscience 2Nile Therapeutics, Inc. Adds to Executive Management Team 2Nile Therapeutics, Inc. Adds to Executive Management Team 3Nile Therapeutics, Inc. Adds to Executive Management Team 4
(Date:4/18/2014)... X-ray crystallography and nuclear magnetic resonance imaging (NMR) to ... but such efforts have long been hampered by the ... molecule and often in ordered and crystalized form to ... peer into the structure of most molecules. , Harvard ... thing of the past. , A team of ...
(Date:4/18/2014)... twist to the story of how barnyard chickens came to ... the journal Proceedings of the National Academy of Sciences ... lived 200-2300 years ago in Europe, researchers report that just ... far different from the chickens we know today. , The ... modern domestic chickens -- such as their yellowish skin -- ...
(Date:4/18/2014)... Calif. A team of researchers led by ... been selected to receive a $7.5 million Department of ... simple and basic scientific foundations for the predictable design ... a wide diversity of structures from plants and animals, ... are taking what biological systems have constructed over millions ...
Breaking Biology News(10 mins):MRI, on a molecular scale 2MRI, on a molecular scale 3Ancient DNA offers clues to how barnyard chickens came to be 2Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3
... have a promising new approach to combating deadly human viruses ... microbiology professor Shou-Wei Ding , and his 20 years ... prove his theory true. Researchers led by Ding, who ... Genome Biology , have discovered that, like plants and invertebrate ...
... of Toronto research has found that purple loosestrife an ... nutrients and can degrade habitats for wildlife has evolved ... spread to northern Ontario. This has allowed populations of ... more than 30-fold increase in seed production. "The ...
... tree species Dracaena kaweesakii from Thailand is characterized ... 12 m in both height and crown diameter, and has ... with bright orange filaments, all highly distinctive features. The study ... access journal Phytokeys by an international ...
Cached Biology News:Researchers discover innate virus-killing power in mammals 2Researchers discover innate virus-killing power in mammals 3Researchers discover innate virus-killing power in mammals 4Natural selection enables purple loosestrife to invade northern Ontario 2
Yellow oily liquid. Contains 85% Drakeol 5NF, 15% Arlacel A (mannide monooleate emulsifier). Heat sterilized. Contains zero colony forming units/ml. ...
... produces output at 470 nm; includes interface cable ... or installed into rack or desktop boxes ... is an LED that produces either pulsed or ... region -- for fluorescence measurements. The source is ...
... LNA microarray slides for microRNA expression ... incorporate Exiqons unique Locked Nucleic Acid (LNA) ... mismatch discrimination for short microRNA (miRNA) targets. ... 1 g total RNA (no need for ...
... Clear amber to slightly cloudy liquid. ... vials per set, each containing 10 ... in the following proportions by weight: ... (mannide monooleate emulsifier), and 0.1% ...
Biology Products: